Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
July 31, 2005
Enrollment
340
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tick-borne encephalitis